{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["LAR", "breast cancer", "relapse", "sE-selectin", "sP-selectin", "treatment", "von Willebrand factor"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "37626742", "DateRevised": {"Year": "2023", "Month": "08", "Day": "28"}, "Article": {"ArticleDate": [{"Year": "2023", "Month": "08", "Day": "10"}], "Language": ["eng"], "ELocationID": ["2246", "10.3390/biomedicines11082246"], "Journal": {"ISSN": "2227-9059", "JournalIssue": {"Volume": "11", "Issue": "8", "PubDate": {"Year": "2023", "Month": "Aug", "Day": "10"}}, "Title": "Biomedicines", "ISOAbbreviation": "Biomedicines"}, "ArticleTitle": "Complex Analysis of Endothelial Markers as Potential Prognostic Indicators in Luminal Invasive Breast Carcinoma Patients: Outcomes of a Six-Year Observational Study.", "Abstract": {"AbstractText": ["(1) Background: Metastasis is a complex process in which the primary cancer cells spread to a distant organ or organs, creating a secondary tumor location, which in many patients leads to treatment failure and death. The aim of the present study was to assess the association of endothelial markers (i.e., sP-selectin, sE-selectin and von Willebrand factor) with the leptin-to-adiponectin ratio (LAR) and to perform an analysis of the predictive value on the survival of patients with luminal A and B invasive breast cancer (IBrC). (2) Methods: The trial included 70 treatment-na\u00efve early-stage IBrC patients with a median age of 54.5 years and a median tumor diameter of 1.5 cm. The median duration of follow-up was 5.7 years, with a relapse rate of 15.71%. Specific immunoenzymatic kits were used to determine pre- and post-treatment concentrations of analyzed factors. (3) Results: Regardless of the treatment pattern, endothelial marker concentrations and the LAR increased after adjuvant treatment. The follow-up showed a significantly higher relapse rate in patients with IBrC who had higher pre-treatment sP-selectin and post-treatment LAR levels. According to receiver operating characteristic (ROC) analysis, a post-treatment LAR with a sensitivity of 88.9% and specificity of 57.9% discriminating cases with or without disease relapse. Additionally, a higher risk of breast cancer relapse was associated with a lower post-treatment sP-selectin concentration. (4) Conclusions: Our results showed mainly that pre-treatment sP-selectin levels and post-treatment LAR may have value as prognostic indicators and may contribute to predicting the future outcomes in patients with early-stage IBrC."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pathophysiology, Faculty of Pharmacy, Nicolaus Copernicus University, Collegium Medicum, 85-094 Bydgoszcz, Poland."}], "LastName": "Kwiatkowska", "ForeName": "Katarzyna", "Initials": "K"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Clinical Ward of Breast Cancer and Reconstructive Surgery, Oncology Centre Prof. F. \u0141ukaszczyk Memorial Hospital, 85-796 Bydgoszcz, Poland."}], "LastName": "Rhone", "ForeName": "Piotr", "Initials": "P"}, {"Identifier": ["0009-0000-3111-7752"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pathophysiology, Faculty of Pharmacy, Nicolaus Copernicus University, Collegium Medicum, 85-094 Bydgoszcz, Poland."}], "LastName": "Koziorzemska", "ForeName": "Paulina", "Initials": "P"}, {"Identifier": ["0000-0001-6691-3863"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medical Chemistry and Laboratory Medicine, Poznan University of Medical Sciences, 60-806 Poznan, Poland."}, {"Identifier": [], "Affiliation": "Department of Stem Cells and Regenerative Medicine, Institute of Natural Fibres and Medicinal Plants-National Research, 62-064 Plewiska, Poland."}], "LastName": "Formanowicz", "ForeName": "Dorota", "Initials": "D"}, {"Identifier": ["0000-0003-4245-2403"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pathophysiology, Faculty of Pharmacy, Nicolaus Copernicus University, Collegium Medicum, 85-094 Bydgoszcz, Poland."}], "LastName": "Ruszkowska-Ciastek", "ForeName": "Barbara", "Initials": "B"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Biomedicines", "NlmUniqueID": "101691304", "ISSNLinking": "2227-9059"}, "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "van Denderen B.J., Thompson E.W. Cancer: The to and fro of tumour spread. Nature. 2013;493:487\u2013488.", "ArticleIdList": ["23344357"]}, {"Citation": "Xu B., Hu X., Feng J., Geng C., Jin F., Li H., Li M., Li Q., Liao N., Liu D., et al. Chinese expert consensus on the clinical diagnosis and treatment of advanced breast cancer (2018) Cancer. 2020;126:3867\u20133882. doi: 10.1002/cncr.32832.", "ArticleIdList": ["10.1002/cncr.32832", "32710660"]}, {"Citation": "O\u2019Shaughnessy J. Extending Survival with Chemotherapy in Metastatic Breast Cancer. Oncologist. 2005;10:20\u201329. doi: 10.1634/theoncologist.10-90003-20.", "ArticleIdList": ["10.1634/theoncologist.10-90003-20", "16368868"]}, {"Citation": "Jin X., Mu P. Targeting Breast Cancer Metastasis. Breast Cancer. 2015;9((Suppl. S1)):23\u201334.", "ArticleIdList": ["PMC4559199", "26380552"]}, {"Citation": "Guo Y., Arciero C.A., Jiang R., Behera M., Peng L., Li X. Different Breast Cancer Subtypes Show Different Metastatic Patterns: A Study from A Large Public Database. Asian Pac. J. Cancer Prev. 2020;21:3587\u20133593. doi: 10.31557/APJCP.2020.21.12.3587.", "ArticleIdList": ["10.31557/APJCP.2020.21.12.3587", "PMC8046324", "33369456"]}, {"Citation": "Gong T.-T., Wu Q.-J., Wang Y.-L., Ma X.-X. Circulating adiponectin, leptin and adiponectin-leptin ratio and endometrial cancer risk: Evidence from a meta-analysis of epidemiologic studies. Int. J. Cancer. 2015;137:1967\u20131978. doi: 10.1002/ijc.29561.", "ArticleIdList": ["10.1002/ijc.29561", "25899043"]}, {"Citation": "Agostinis-Sobrinho C., Vicente S.E.C.F., Norkiene S., Rauckien\u0117-Michaelsson A., Kievisien\u0117 J., Dubey V.P., Razbadauskas A., Lopes L., Santos R. Is the Leptin/Adiponectin Ratio a Better Diagnostic Biomarker for Insulin Resistance than Leptin or Adiponectin Alone in Adolescents? Children. 2022;9:1193. doi: 10.3390/children9081193.", "ArticleIdList": ["10.3390/children9081193", "PMC9406389", "36010082"]}, {"Citation": "Borsig L., Laubli H. Cell Adhesion during Tumorigenesis and Metastasis. In: Boffetta P., Hainaut P., editors. Encyclopedia of Cancer. 3rd ed. Elsevier; Amsterdam, The Netherlands: 2019. pp. 307\u2013314."}, {"Citation": "Drnasfield I., Stocks S.C., Haslett C. Regulation of cell adhesion molecule expression and function associated with neutrophil apoptosis. Blood. 1995;85:3264\u20133273. doi: 10.1182/blood.V85.11.3264.bloodjournal85113264.", "ArticleIdList": ["10.1182/blood.V85.11.3264.bloodjournal85113264", "7538822"]}, {"Citation": "Abdal Dayem A., Lee S., YChoi H., Cho S.G. The Impact of Adhesion Molecules on the In Vitro Culture and Differentiation of Stem Cells. Biotechnol. J. 2018;13:1700575.", "ArticleIdList": ["29193872"]}, {"Citation": "Ley K. Mammalian Carbohydate Recognition System. Volume 33. Springer; Berlin/Heidelberg, Germany: 2001. Functions of selectins; pp. 177\u2013200.", "ArticleIdList": ["10.1007/978-3-540-46410-5_10", "11190674"]}, {"Citation": "Tinoco R., Otero D.C., Takahashi A.A., Bradley L.M. PSGL-1: A new player in the immune checkpoint landscape. Trends Immunol. 2017;38:323\u2013335. doi: 10.1016/j.it.2017.02.002.", "ArticleIdList": ["10.1016/j.it.2017.02.002", "PMC5411281", "28262471"]}, {"Citation": "Alves C.S., Burdick M.M., Thomas S.N., Pawar P., Konstantopoulos K. The dual role of CD44 as a functional P-selectin ligand and fibrin receptor in colon carcinoma cell adhesion. Am. J. Physiol.-Cell Physiol. 2008;294:C907\u2013C916. doi: 10.1152/ajpcell.00463.2007.", "ArticleIdList": ["10.1152/ajpcell.00463.2007", "18234849"]}, {"Citation": "Mannori G., Crottet P., Cecconi O., Hanasaki K., Aruffo A., Nelson R.M., Varki A., Bevilacqua M.P. Differential colon cancer cell adhesion to E-, P-, and L-selectin: Role of mucin-type glycoproteins. Cancer Res. 1995;55:4425\u20134431.", "ArticleIdList": ["7545541"]}, {"Citation": "Gout S., Morin C., Houle F., Huot J. Death receptor-3, a new E-Selectin counter-receptor that confers migration and survival advantages to colon carcinoma cells by triggering p38 and ERK MAPK activation. Cancer Res. 2006;66:9117\u20139124. doi: 10.1158/0008-5472.CAN-05-4605.", "ArticleIdList": ["10.1158/0008-5472.CAN-05-4605", "16982754"]}, {"Citation": "Schrijver I.T., Kemperman H., Roest M., Kesecioglu J., de Lange D.W. Soluble P-selectin as a Biomarker for Infection and Survival in Patients with a Systemic Inflammatory Response Syndrome on the Intensive Care Unit. Biomark. Insights. 2017;12:1177271916684823. doi: 10.1177/1177271916684823.", "ArticleIdList": ["10.1177/1177271916684823", "PMC5345948", "28469394"]}, {"Citation": "Pang J.H., Coupland L.A., Freeman C., Chong B.H., Parish C.R. Activation of tumour cell ECM degradation by thrombin-activated platelet membranes: Potentially a P-selectin and GPIIb/IIIa-dependent process. Clin. Exp. Metastasis. 2015;32:495\u2013505. doi: 10.1007/s10585-015-9722-5.", "ArticleIdList": ["10.1007/s10585-015-9722-5", "25982688"]}, {"Citation": "Coupland L.A., Chong B.H., Parish C.R. Platelets and P-selectin control tumor cell metastasis in an organ-specific manner and independently of NK cells. Cancer Res. 2012;72:4662\u20134671. doi: 10.1158/0008-5472.CAN-11-4010.", "ArticleIdList": ["10.1158/0008-5472.CAN-11-4010", "22836751"]}, {"Citation": "Franchini M., Frattini F., Crestani S., Bonfanti C., Lippi G. von Willebrand factor and cancer: A renewed interest. Thromb. Res. 2013;13:290\u2013292. doi: 10.1016/j.thromres.2013.01.015.", "ArticleIdList": ["10.1016/j.thromres.2013.01.015", "23394808"]}, {"Citation": "Dhami S.P.S., Patmore S., Comerford C., Byrne C.M., Cavanagh B., Castle J., Kirwan C.C., Kenny M., Schoen I., O\u2019Donnell J.S., et al. Breast cancer cells mediate endothelial cell activation, promoting von Willebrand factor release, tumor adhesion, and transendothelial migration. J. Thromb. Haemost. 2022;20:2350\u20132365. doi: 10.1111/jth.15794.", "ArticleIdList": ["10.1111/jth.15794", "PMC9796425", "35722954"]}, {"Citation": "Rhone P., Zarychta E., Bielawski K., Ruszkowska-Ciastek B. Pre-surgical level of von Willebrand factor as an evident indicator of breast cancer recurrence. Cancer Biomark. 2020;29:359\u2013372. doi: 10.3233/CBM-191096.", "ArticleIdList": ["10.3233/CBM-191096", "32716345"]}, {"Citation": "Nalabolu M.R., Palasamudram K., Jamil K. Adiponectin and leptin molecular actions and clinical significance in breast cancer. Int. J. Hematol. Oncol. Stem Cell Res. 2014;8:31\u201340.", "ArticleIdList": ["PMC3913152", "24505549"]}, {"Citation": "Dal Maso L., Augustin L.S., Karalis A., Talamini R., Franceschi S., Trichopoulos D., Mantzoros C.S., La Vecchia C. Circulating adiponectin and endometrial cancer risk. J. Clin. Endocrinol. Metab. 2004;89:1160\u20131163.", "ArticleIdList": ["15001602"]}, {"Citation": "Goktas S., Yilmaz M.I., Caglar K., Sonmez A., Kilic S., Bedir S. Prostate cancer and adiponectin. Urology. 2005;65:1168\u20131172. doi: 10.1016/j.urology.2004.12.053.", "ArticleIdList": ["10.1016/j.urology.2004.12.053", "15922427"]}, {"Citation": "S\u0142omian G.J., Nowak D., Buczkowska M., G\u0142ogowska-Gruszka A., S\u0142omian S.P., Roczniak W., Janyga S., Nowak P. The role of adiponectin and leptin in the treatment of ovarian cancer patients. Endokrynol. Pol. 2019;70:57\u201363. doi: 10.5603/EP.a2018.0081.", "ArticleIdList": ["10.5603/EP.a2018.0081", "30450532"]}, {"Citation": "Iwan-Zietek I., Ruszkowska-Ciastek B., Michalska M., Overskaug E., Goralczyk K., Dabrowiecki S., R\u00f3\u015b\u0107 D. Association of adiponectin and leptin-to-adiponectin ratio with the function of platelets in morbidly obese patients. J. Physiol. Pharmacol. Off. J. Pol. Physiol. Soc. 2016;67:555\u2013561.", "ArticleIdList": ["27779476"]}, {"Citation": "Sung H., Ferlay J., Siegel R.L., Laversanne M., Soerjomataram I., Jemal A., Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J. Clin. 2021;71:209\u2013249. doi: 10.3322/caac.21660.", "ArticleIdList": ["10.3322/caac.21660", "33538338"]}, {"Citation": "Williams E.D., Gao D., Redfern A., Thompson E.W. Controversies around epithelial-mesenchymal plasticity in cancer metastasis. Nat. Rev. Cancer. 2019;19:716\u2013732. doi: 10.1038/s41568-019-0213-x.", "ArticleIdList": ["10.1038/s41568-019-0213-x", "PMC7055151", "31666716"]}, {"Citation": "Park M., Kim D., Ko S., Kim A., Mo K., Yoon H. Breast Cancer Metastasis: Mechanisms and Therapeutic Implications. Int. J. Mol. Sci. 2022;23:6806. doi: 10.3390/ijms23126806.", "ArticleIdList": ["10.3390/ijms23126806", "PMC9224686", "35743249"]}, {"Citation": "Sun J., Zhang R., Tang J., Wu X., Zhu L., Huang H., Chen H., Xiao M., Luo H., Zheng H., et al. Prognostic Observational Analysis of BMI, Leptin, and Adiponectin in Children With Acute Lymphocytic Leukemia Undergoing Remission-Induction Chemotherapy. Front. Pediatr. 2022;10:797836. doi: 10.3389/fped.2022.797836.", "ArticleIdList": ["10.3389/fped.2022.797836", "PMC8978674", "35386254"]}, {"Citation": "Picon-Ruiz M., Morata-Tarifa C., Valle-Goffin J.J., Friedman E.R., Slingerland J.M. Obesity and adverse breast cancer risk and outcome: Mechanistic insights and strategies for intervention. CA Cancer J. Clin. 2017;67:378\u2013397.", "ArticleIdList": ["PMC5591063", "28763097"]}, {"Citation": "Christodoulatos G.S., Spyrou N., Kadillari J., Psallida S., Dalamaga M. The role of adipokines in breast cancer: Current evidence and perspectives. Curr. Obes. Rep. 2019;8:413\u2013433.", "ArticleIdList": ["31637624"]}, {"Citation": "Siemi\u0144ska L., Borowski A., Marek B., Nowak M., Kajdaniuk D., Warakomski J., Kos-Kud\u0142a B. Serum concentrations of adipokines in men with prostate cancer and benign prostate hyperplasia. Endokrynol. Pol. 2018;69:120\u2013127.", "ArticleIdList": ["29465157"]}, {"Citation": "Morad V., Abrahamsson A., Dabrosin C. Estradiol affects extracellular leptin:adiponectin ratio in human breast tissue in vivo. J. Clin. Endocrinol. Metab. 2014;99:3460\u20133467. doi: 10.1210/jc.2014-1129.", "ArticleIdList": ["10.1210/jc.2014-1129", "24796929"]}, {"Citation": "Kang S.A., Blache C.A., Bajana S., Hasan N., Kamal M., Morita Y., Gupta V., Tsolmon B., Suh K.S., Gorenstein D.G., et al. The effect of soluble E-selectin on tumor progression and metastasis. BMC Cancer. 2016;16:331.", "ArticleIdList": ["PMC4879723", "27220365"]}, {"Citation": "Ramcharan K.S., Lip G.Y., Stonelake P.S., Blann A.D. Effect of standard chemotherapy and antiangiogenic therapy on plasma markers and endothelial cells in colorectal cancer. Br. J. Cancer. 2014;111:1742\u20131749. doi: 10.1038/bjc.2014.491.", "ArticleIdList": ["10.1038/bjc.2014.491", "PMC4453738", "25211664"]}, {"Citation": "Mann A.P., Tanaka T. E-selectin: Its role in cancer and potential as a biomarker. Transl. Med. 2011;S1:002."}, {"Citation": "Muz B., Abdelghafer A., Markovic M., Yavner J., Melam A., Salama N.N., Azab A.K. Targeting E-selectin to Tackle Cancer Using Uproleselan. Cancers. 2021;13:335. doi: 10.3390/cancers13020335.", "ArticleIdList": ["10.3390/cancers13020335", "PMC7831123", "33477563"]}, {"Citation": "Mills P.J., Ancoli-Israel S., Parker B., Natarajan L., Hong S., Jain S., Sadler G.R., von K\u00e4nel R. Predictors of inflammation in response to anthracycline-based chemotherapy for breast cancer. Brain Behav. Immun. 2008;22:98\u2013104. doi: 10.1016/j.bbi.2007.07.001.", "ArticleIdList": ["10.1016/j.bbi.2007.07.001", "PMC2199880", "17706918"]}, {"Citation": "Gil-Bazo I., Catal\u00e1n Goni V., Alonso Guti\u00e9rrez A., Rodr\u00edguez Rodr\u00edguez J., P\u00e1ramo Fern\u00e1ndez J.A., de la C\u00e1mara G\u00f3mez J., Hern\u00e1ndez Lizoain J.L., Garc\u00eda-Foncillas L\u00f3pez J. Impact of surgery and chemotherapy on von Willebrand factor and vascular endothelial growth factor levels in colorectal cancer. Clin. Transl. Oncol. Off. Public Fed. Span. Oncol. Soc. Natl. Cancer Inst. Mex. 2005;7:150\u2013155. doi: 10.1007/BF02708752.", "ArticleIdList": ["10.1007/BF02708752", "15960922"]}, {"Citation": "Giri S., Bose J.C., Chandrasekar A., Tiwary B.K., Gajalakshmi P., Chatterjee S. Increased Plasma Nitrite and von Willebrand Factor Indicates Early Diagnosis of Vascular Diseases in Chemotherapy Treated Cancer Patients. Cardiovasc. Toxicol. 2019;19:36\u201347. doi: 10.1007/s12012-018-9471-1.", "ArticleIdList": ["10.1007/s12012-018-9471-1", "29974375"]}, {"Citation": "Liu J., Lin P.C., Zhou B.P. Inflammation fuels tumor progress and metastasis. Curr. Pharm. Des. 2015;21:3032\u20133040. doi: 10.2174/1381612821666150514105741.", "ArticleIdList": ["10.2174/1381612821666150514105741", "PMC5644345", "26004407"]}, {"Citation": "Ma\u015blanka K. The role of platelets in inflammatory processes. J. Transfus. Med. 2014;7:102\u2013109."}, {"Citation": "Weller A., Isenmann S., Vestweber D. Cloning of the mouse endothelial selectins. Expression of both E- and P-selectin is inducible by tumor necrosis factor alpha. J. Biol. Chem. 1992;267:15176\u201315183. doi: 10.1016/S0021-9258(18)42162-X.", "ArticleIdList": ["10.1016/S0021-9258(18)42162-X", "1378846"]}, {"Citation": "Woollard K.J., Chin-Dusting J. P-selectin antagonism in inflammatory disease. Curr. Pharm. Des. 2010;16:4113\u20134118. doi: 10.2174/138161210794519192.", "ArticleIdList": ["10.2174/138161210794519192", "21247396"]}, {"Citation": "Ay C., Simanek R., Vormittag R., Dunkler D., Alguel G., Koder S., Kornek G., Marosi C., Wagner O., Zielinski C., et al. High plasma levels of soluble P-selectin are predictive of venous thromboembolism in cancer patients: Results from the Vienna Cancer and Thrombosis Study (CATS) Blood. 2008;112:2703\u20132708. doi: 10.1182/blood-2008-02-142422.", "ArticleIdList": ["10.1182/blood-2008-02-142422", "18539899"]}, {"Citation": "den Berg Y.W., Osanto S., Reitsma P.H., Versteeg H.H. The relationship between tissue factor and cancer progression: Insights from bench and bedside. Blood. 2012;119:924\u2013932.", "ArticleIdList": ["22065595"]}, {"Citation": "Ferroni P., Roselli M., Martini F., D\u2019Alessandro R., Mariotti S., Basili S., Spila A., Aloe S., Palmirotta R., Maggini A., et al. Prognostic value of soluble P-selectin levels in colorectal cancer. Int. J. Cancer. 2004;111:404\u2013408. doi: 10.1002/ijc.20189.", "ArticleIdList": ["10.1002/ijc.20189", "15221968"]}, {"Citation": "Graf M.E., Sookthai D., Johnson T., Sch\u00fcbel R., Gonz\u00e1lez Maldonado S., Pletsch-Borba L., Katzke V., Bugert P., Hoffmeister M., Kaaks R., et al. Pre-diagnostic plasma concentrations of Fibrinogen, sGPIIb/IIIa, sP-selectin, sThrombomodulin, Thrombopoietin in relation to cancer risk: Findings from a large prospective study. Int. J. Cancer. 2018;143:2659\u20132667.", "ArticleIdList": ["29923180"]}, {"Citation": "Alexandrakis M.G., Passam F.H., Sfiridaki K., Kafarakis P., Karydi E., Liapi D., Perisinakis K., Kyriakou D.S. Clinical significance of circulating endothelial adhesion molecules (sE-selectin and sICAM) in untreated multiple myeloma patients. Clin. Chim. Acta. 2004;349:39\u201343. doi: 10.1016/j.cccn.2004.05.025.", "ArticleIdList": ["10.1016/j.cccn.2004.05.025", "15469853"]}, {"Citation": "Diaz E.S., Karlan B.Y., Li A.J. Obesity-associated adipokines correlate with survival in epithelial ovarian cancer. Gynecol. Oncol. 2013;129:353\u2013357. doi: 10.1016/j.ygyno.2013.02.006.", "ArticleIdList": ["10.1016/j.ygyno.2013.02.006", "23402904"]}, {"Citation": "Terraube V., Pendu R., Baruch D., Gebbink M.F., Meyer D., Lenting P.J., Denis C.V. Increased metastatic potential of tumor cells in von Willebrand factor-deficient mice. J. Thromb. Haemost. JTH. 2006;4:519\u2013526. doi: 10.1111/j.1538-7836.2005.01770.x.", "ArticleIdList": ["10.1111/j.1538-7836.2005.01770.x", "16405520"]}, {"Citation": "Tigges U., Hyer E.G., Scharf J., Stallcup W.B. FGF2-dependent neovascularization of subcutaneous Matrigel plugs is initiated by bone marrow-derived pericytes and macrophages. Development. 2008;35:523\u2013532. doi: 10.1242/dev.002071.", "ArticleIdList": ["10.1242/dev.002071", "18171688"]}, {"Citation": "P\u00e9pin M., Kleinjan A., Hajage D., B\u00fcller H.R., Di Nisio M., Kamphuisen P.W., Salomon L., Veyradier A., Stepanian A., Mah\u00e9 I. ADAMTS-13 and von Willebrand factor predict venous thromboembolism in patients with cancer. J. Thromb. Haemost. 2016;14:306\u2013315. doi: 10.1111/jth.13205.", "ArticleIdList": ["10.1111/jth.13205", "26589836"]}], "ReferenceList": []}], "History": [{"Year": "2023", "Month": "5", "Day": "27"}, {"Year": "2023", "Month": "7", "Day": "22"}, {"Year": "2023", "Month": "8", "Day": "9"}, {"Year": "2023", "Month": "8", "Day": "26", "Hour": "10", "Minute": "47"}, {"Year": "2023", "Month": "8", "Day": "26", "Hour": "10", "Minute": "46"}, {"Year": "2023", "Month": "8", "Day": "26", "Hour": "1", "Minute": "1"}, {"Year": "2023", "Month": "8", "Day": "10"}], "PublicationStatus": "epublish", "ArticleIdList": ["37626742", "PMC10452676", "10.3390/biomedicines11082246", "biomedicines11082246"]}}], "PubmedBookArticle": []}